Keywords: novo, nordisk, profits, up, takes, mill, charge
Novo Nordisk Profits Up, Takes $31.3 Mill Charge
Article | 17 November 1998
Danish pharmaceutical company Novo Nordisk has posted solid figures forthe first nine months of 1998, with pretax profits rising 21% to 2.79 billion ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Australia's pharma industry applauds R&D regulatory reform
